HBK Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

HBK Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,779	Closed	-$425K	–	1280
2018 Q3	$425K	Buy	3,779 +979	+35%	+$103K	﹤0.01%	974
2018 Q2	$258K	Sell	2,800 -5,599	-67%	-$543K	﹤0.01%	925
2018 Q1	$838K	Buy	8,399 +5,412	+181%	+$583K	0.01%	659
2017 Q4	$280K	Sell	2,987 -9,504	-76%	-$899K	﹤0.01%	867
2017 Q3	$1.27M	Sell	12,491 -4,809	-28%	-$420K	0.01%	565
2017 Q2	$1.32M	Buy	+17,300	New	+$1.46M	0.01%	508

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

HBK Investments's LKFT Position: Q4 2018 in Review

HBK Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018, closing a stake of 3,779 shares — an estimated $425K sold.

HBK Investments first reported a position in LKFT in Q2 2017 and held it in 6 quarters. The position peaked at $1.32M in Q2 2017. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.

HBK Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2018 after selling out during the quarter.
HBK Investments sold 3,779 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2018, an estimated $425K.
HBK Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 6 quarters.
HBK Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.32M in Q2 2017.
85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.

Based on HBK Investments's 13F filing for Q4 2018, filed 14 Feb 2019.